| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 139.877 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 117.348 | 77 |
| GSM780709 | Untreated after 4 days (C3_1) | 112.592 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 127.227 | 78 |
| GSM780720 | Untreated after 4 days (C2_2) | 139.066 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 97.46 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 146.367 | 80 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 132.513 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 171.192 | 82 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 128.92 | 79 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 150.627 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 173.587 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 91.9529 | 74 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 134.465 | 79 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 115.012 | 77 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 91.2197 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 125.892 | 78 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 120.353 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 152.722 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 138.993 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 160.269 | 81 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 124.833 | 78 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 137.314 | 79 |